药物研发公司Metrion Biosciences与Sosei Heptares宣布达成战略合作-动脉橙

药物研发公司Metrion Biosciences与Sosei Heptares宣布达成战略合作

2021-02-01 prnewswire 等3家媒体报道商业合作





2021年2月1日，药物研发公司Metrion Biosciences Limited与Sosei Group Corporation宣布双方将通过新的战略合作，首次将Sosei Heptares领先的基于结构的药物设计（SBDD）专业技术和平台应用于离子通道。

关联公司

 Metrion BiosciencesNxera

2021-02-01 Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences

prnewswire
2021-02-01 Metrion Biosciences and Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration

businesswire
2021-02-01 Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences

biospace

扫码咨询在线客服